Gut microbial-derived butyrate is inversely associated with IgE responses to allergens in childhood asthmaOriginal paper
What was studied?
This study asked how specific gut bacteria and their metabolites relate to allergen sensitization in childhood rhinitis and asthma. It combined fecal metabolomics with microbiome profiling and linked both to allergen-specific IgE levels. Stool metabolites were measured by proton nuclear magnetic resonance spectroscopy. Gut microbiome composition was assessed by bacterial 16S ribosomal RNA sequencing. Associations with allergen-specific IgE were then analyzed together.
Who was studied?
The cohort was 85 children in Taiwan. It included 27 children with allergic rhinitis, 34 with asthma, and 24 healthy controls. All were young children, making this a pediatric human study. Fecal samples provided both the metabolome and the microbiome data. Serum was used to measure total and allergen-specific IgE, including house dust mite allergen sensitization.
What were the most important findings?
Butyrate metabolites were significantly reduced in children with asthma (P = 0.009) and histidine in children with rhinitis (P = 0.029). The phylum Firmicutes was significantly lower in rhinitis and asthma children. In asthma, butyrate-producing Faecalibacterium and Roseburia fell while Clostridium rose. Increased Escherichia accompanied more beta-alanine and 4-hydroxybutyrate. Low fecal butyrate was significantly linked to higher total serum and mite-specific IgE (P < 0.05).
What are the greatest implications of this study?
The findings connect a shift away from butyrate-producing gut bacteria to allergen sensitization in early childhood asthma. Low fecal butyrate tracked with higher mite-specific IgE and asthma risk. The authors propose fecal beta-alanine as a possible biomarker linking gut dysbiosis, involving Clostridium and Escherichia, to childhood asthma. These are correlations, so the data do not establish that low butyrate causes sensitization.